Skip to content
← Back to this collection

PUBLICATIONS · 39447094

Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2025 Feb 13
First author
Sehn LH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2025 Feb 13;145(7):655-657. doi: 10.1182/blood.2024027223.
    note
    Source null
    related pmid
    39946154
    relationship
    Comment in

Authors and identifiers

  1. name
    Sehn LH
    type
    Author
  2. name
    Bartlett NL
    type
    Author
  3. name
    Matasar MJ
    type
    Author
  4. name
    Schuster SJ
    type
    Author
  5. name
    Assouline SE
    type
    Author
  6. name
    Giri P
    type
    Author
  7. name
    Kuruvilla J
    type
    Author
  8. name
    Shadman M
    type
    Author
  9. name
    Cheah CY
    type
    Author
  10. name
    Dietrich S
    type
    Author
  11. name
    Fay K
    type
    Author
  12. name
    Ku M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Sehn LH
    type
    Author
  2. name
    Bartlett NL
    type
    Author
  3. name
    Matasar MJ
    type
    Author
  4. name
    Schuster SJ
    type
    Author
  5. name
    Assouline SE
    type
    Author
  6. name
    Giri P
    type
    Author
  7. name
    Kuruvilla J
    type
    Author
  8. name
    Shadman M
    type
    Author
  9. name
    Cheah CY
    type
    Author
  10. name
    Dietrich S
    type
    Author
  11. name
    Fay K
    type
    Author
  12. name
    Ku M
    type
    Author
bibliography ids
  1. nci-bib-aef56a761ffb9aa598e1300f
book metadata
content sha256
794aaaafc0bf8dcf91d50fbbadec1dc7610f2527f89d6c4f830c1097663ed51d
document type
citation
dois
  1. 10.1182/blood.2024025454
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:39447094
immutable id
pubmed:39447094@794aaaafc0bf8dcf91d50fbbadec1dc7610f2527f89d6c4f830c1097663ed51d
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
7
name
Blood
nlm unique id
7603509
pages
708-719
volume
145
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2025 Feb 13;145(7):655-657. doi: 10.1182/blood.2024027223.
    note
    Source null
    related pmid
    39946154
    relationship
    Comment in
outcomes validated
false
pmid
39447094
provenance
batch id
3e43afde6f26fc8df6da
provider
NCBI PubMed ESummary
record sha256
b2136f04bc98239e7c34345a693cd183afa891b0e5c9d65c18012d29de453e37
response sha256
fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
retrieved at
2026-09-09T23:48:21.145285+00:00
publication date
display
2025 Feb 13
precision
day
year
2025
publication types
  1. Journal Article
  2. Clinical Trial, Phase II
  3. Clinical Trial, Phase I
  4. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/39447094/
title
Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies.

Preserved source evidence · Independent clinical review pending · Not medical advice